Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2013 Oct;57(10):5195–5196. doi: 10.1128/AAC.00995-13

Increased Emergence of Fluoroquinolone-Resistant Campylobacter jejuni in Biofilm

Junghee Bae 1, Byeonghwa Jeon 1,
PMCID: PMC3811428  PMID: 23896469

LETTER

Campylobacter jejuni is a leading food-borne pathogen that annually causes approximately 400 million to 500 million human infection cases worldwide (1). As a zoonotic pathogen, C. jejuni colonizes the intestines of various animal species, particularly poultry, and is transmitted to humans via consumption of contaminated foods (1). Antibiotic treatment is warranted for serious cases of human campylobacteriosis (2); however, the increasing prevalence of Campylobacter isolates resistant to clinically important antibiotics, such as fluoroquinolones (FQs) and macrolides, has often been implicated in adverse patient outcomes and is considered a serious public health problem (3).

Enhanced mutability in biofilm has been reported to occur in some bacterial species, and this mutability changes affect the occurrence of spontaneous mutations associated with antibiotic resistance (4, 5). Although C. jejuni is known to form biofilm (6) and FQ resistance (FQR) is primarily caused by point mutations in DNA gyrase A (2), it has not been understood whether biofilm would have an impact on C. jejuni's development of FQR. In this study, C. jejuni NCTC 11168 was maintained on Mueller-Hinton (MH; Oxoid) agar plates at 42°C microaerobically (5% O2, 10% CO2, and 85% N2). C. jejuni biofilm formation was carried out according to a method described elsewhere (7). Briefly, overnight culture of C. jejuni was resuspended in MH broth to give an optical density at 600 nm (OD600) of 0.07, and the bacterial liquid culture was grown with shaking (200 rpm) to dissociate bacterial cells to a planktonic stage prior to inoculation. After incubation with shaking for 4 h, the liquid culture was diluted with fresh MH broth, making the OD600 approximately 0.07. Sterile 24-well plates were inoculated with 1 ml of C. jejuni suspension and incubated for 24 h without agitation. The supernatant was used to determine the frequency of FQR development in planktonic cells. Biofilm formed in 24-well plates was washed with phosphate-buffered saline (PBS) three times, and 1 ml of fresh MH broth was added to the biofilm. By this procedure, C. jejuni cells that were released from the biofilm were allowed to grow in MH broth because C. jejuni biofilms continuously shed bacterial cells (6). After 24 h of incubation, supernatant was collected for measurement of the frequency of FQR development in C. jejuni cells dispersed from biofilm. Total bacterial count was determined by performing serial dilution and culturing on MH agar plates. MH agar plates supplemented with ciprofloxacin at 1×, 2×, and 4× the MIC (0.125 μg ml−1, 0.25 μg ml−1, and 0.5 μg ml−1, respectively) were used to determine the counts of FQ-resistant cells. Resistant colonies were randomly selected and subjected to Etest (bioMérieux) to determine the level of FQR. The MIC of ciprofloxacin as determined by Etest is known to correlate with the MIC as measured with standard antimicrobial susceptibility testing, such as broth microdilution or agar dilution (8). The quality control strain C. jejuni ATCC 33560 was included in the test.

C. jejuni cells from biofilm demonstrated significantly (P = 0.006) higher frequencies of FQR than planktonic cells, approximately 3.2-fold, at 1× the MIC of ciprofloxacin (Table 1). The mean values of FQR frequency were also higher in biofilm than in planktonic cells at 2× and 4× the MIC (Table 1). Based on the results of the ciprofloxacin susceptibility test, however, biofilm did not make differences in the emergence of FQR exceeding the breakpoint MIC of ciprofloxacin (4 μg ml−1) suggested by the Clinical and Laboratory Standards Institute (CLSI) (9), compared to planktonic cells (data not shown). C. jejuni's ability to form biofilms is important for human infection and survival in harsh environments (10, 11). Interestingly, it has been reported that high numbers of Campylobacter spp. are isolated from naturally present biofilms (12). By extrapolation of previous reports and the results in this study, it can be speculated that Campylobacter-harboring biofilms may release Campylobacter cells with increased FQR.

Table 1.

FQR frequencies in biofilms and planktonic cells of C. jejunia

Culture MIC (μg/ml)
Biofilm (2.69 ± 3.60) × 10−7* (1.17 ± 1.91) × 10−7 (6.39 ± 3.84) × 10−8
Planktonic (8.48 ± 5.36) × 10−8 (1.85 ± 0.97) × 10−8 (1.09 ± 0.10) × 10−8
a

The MIC of ciprofloxacin is 0.125 μg ml−1. FQR frequency was calculated by dividing the number of FQ-resistant colonies by the total bacterial count. The values shown are the means and standard deviations of results from five independent experiments. Statistical significance of FQR frequency between planktonic cells and biofilms was analyzed by using an unpaired Mann-Whitney two-sample test. *, P < 0.01.

In this study, we showed that C. jejuni biofilm is involved in enhanced FQR. Although the molecular details will be elucidated in future studies, the results successfully demonstrate that biofilm formation is implicated in the development of C. jejuni's resistance to FQ, an antibiotic class of clinical importance.

ACKNOWLEDGMENTS

This study was supported by an NSERC Discovery Grant (401843-2012-RGPIN) and intramural funding from the University of Alberta.

We thank Lynn McMullen and Michael Gaenzle (University of Alberta) for sharing laboratory facilities.

Footnotes

Published ahead of print 29 July 2013

REFERENCES

  • 1.Ruiz-Palacios GM. 2007. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin. Infect. Dis. 44:701–703 [DOI] [PubMed] [Google Scholar]
  • 2.Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4:189–200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Helms M, Simonsen J, Olsen KE, Molbak K. 2005. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J. Infect. Dis. 191:1050–1055 [DOI] [PubMed] [Google Scholar]
  • 4.Driffield K, Miller K, Bostock JM, O'Neill AJ, Chopra I. 2008. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrob. Chemother. 61:1053–1056 [DOI] [PubMed] [Google Scholar]
  • 5.Boles BR, Singh PK. 2008. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl. Acad. Sci. U. S. A. 105:12503–12508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Reuter M, Mallett A, Pearson BM, van Vliet AH. 2010. Biofilm formation by Campylobacter jejuni is increased under aerobic conditions. Appl. Environ. Microbiol. 76:2122–2128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McLennan MK, Ringoir DD, Frirdich E, Svensson SL, Wells DH, Jarrell H, Szymanski CM, Gaynor EC. 2008. Campylobacter jejuni biofilms up-regulated in the absence of the stringent response utilize a calcofluor white-reactive polysaccharide. J. Bacteriol. 190:1097–1107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Luber P, Bartelt E, Genschow E, Wagner J, Hahn H. 2003. Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J. Clin. Microbiol. 41:1062–1068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Clinical and Laboratory Standards Institute 2010. Methods for antimicrobial dilution and disk susceptibility testing for infrequently-isolated or fastidious bacteria: approved guidelines. Publication no. M45-A2. Clinical and Laboratory Standards Institute, Wayne, PA: [DOI] [PubMed] [Google Scholar]
  • 10.Haddock G, Mullin M, MacCallum A, Sherry A, Tetley L, Watson E, Dagleish M, Smith DG, Everest P. 2010. Campylobacter jejuni 81-176 forms distinct microcolonies on in vitro-infected human small intestinal tissue prior to biofilm formation. Microbiology 156:3079–3084 [DOI] [PubMed] [Google Scholar]
  • 11.Young KT, Davis LM, Dirita VJ. 2007. Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5:665–679 [DOI] [PubMed] [Google Scholar]
  • 12.Maal-Bared R, Bartlett KH, Bowie WR, Hall ER. 2012. Campylobacter spp. distribution in biofilms on different surfaces in an agricultural watershed (Elk Creek, British Columbia): using biofilms to monitor for Campylobacter. Int. J. Hyg. Environ. Health 215:270–278 [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES